IPO Premiums
IPO calendar
MDMDRCLListed

Modern Diagnostic & Research Centre Limited

Bookbuilding IPO · BSE

Price band
₹85 - ₹90
Lot size
1,600 shares
Issue amount
₹37 cr
Total subscription
376.97×
Current price₹62.62
Listing price ₹99.5
Watch live price ↗
Opens
31 Dec 2025
Closes
2 Jan 2026
Allotment
5 Jan 2026
Listing
7 Jan 2026

Offer at a glance

Issue overview

Issue size
40,99,200 shares
Face value
₹10 per share
Minimum investment
₹1,36,000
Fresh issue
₹37 cr
Offer for sale
₹0 cr
Registrar
Link Intime India Private Limited
Listing exchange
BSE
Maximum investment
₹1,44,000
Issue type
Bookbuilding IPO
Shares before issue
1,10,00,000
Shares after issue
1,50,99,200

Lot sizes

CategoryLotsSharesAmount
RETAIL23,200₹2,88,000
sHNI34,800₹4,32,000
bHNI711,200₹10,08,000

Share reservation

ANCHOR28.34%
QIB19.09%
HNI14.29%
RETAIL33.26%
Market Maker5.04%

Subscription & GMP

Subscription by category

Total subscribed376.97×

Reported 2 Jan 2026

QIB193.51×
NIB702.43×
RETAIL342.46×
HNIs(10L+)863.37×
HNIs(2-10L)380.57×

GMP history

07.51526 Dec: ₹027 Dec: ₹530 Dec: ₹1030 Dec: ₹101 Jan: ₹126 Jan: ₹15
26 Dec₹156 Jan

Day-wise demand

31 Dec5.92×
1 Jan30.94×
2 Jan376.97×

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL4261,45,889
HNIs(10L +)8128,729
HNIs (2-10L)4114,791

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs7.041,362.6
RETAIL12.274,201.6
NIB5.273,702.11
HNIs 2+1.76668.58
HNIs 10+3.513,033.53

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
-50050100Mar-23 · Revenue: 56.61Mar-23 · Profit after tax: -5.73Mar-23Mar-24 · Revenue: 68.67Mar-24 · Profit after tax: 5.79Mar-24Mar-25 · Revenue: 78.8Mar-25 · Profit after tax: 8.97Mar-25Jun-25 · Revenue: 22.67Jun-25 · Profit after tax: 3Jun-25
RevenueProfit after tax

Key performance indicators

MetricJun-25Mar-25Mar-24Mar-23
EPS0000
ROE13.4955.2165.4-64.92
ROCE9.5436.1825.27-17.18
RONW0000
PRE IPO(PE)011.0400
POST IPO(PE)11.33000

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Vijaya Diagnostic Centre Ltd72.360177.4218.0713.92
Modern Diagnostic & Research Centre Ltd001018.8443.278.15

Company information

Company profile

Incorporated in 1985, Modern Diagnostic & Research Centre Limited is an India-based diagnostic service provider offering a wide range of pathology and radiology services to patients and institutions. The company delivers reliable diagnostic testing along with home sample collection, online report access, and customized health packages designed to meet individual and institutional requirements. It operates 21 centres, including 17 laboratories and 4 diagnostic centres, spread across 8 states, and provides services such as ultrasound, CT scan, MRI, X-ray, ECG, PFT, and specialized diagnostic facilities for cardiac and neurological care. Its pathology services cover routine tests as well as advanced molecular diagnostics, cytogenetics, and specialized testing for genetic disorders and cancer, while radiology services include MRI, CT scans, ultrasound, and digital X-rays using modern equipment. As of February 28, 2025, the company has a workforce of 570 employees, including doctors and consultants.

Strengths

  • Wide diagnostic service portfolio: Offers comprehensive pathology and radiology services, including advanced imaging and specialised tests for cardiac, neurological, genetic, and cancer diagnostics.
  • Strong operational network: Operates 21 centres across 8 states, enabling wider reach and improved accessibility for patients and institutional clients.
  • Experienced medical workforce: Backed by qualified doctors, consultants, and technical staff, ensuring reliable testing, accurate reports, and consistent service quality.

Risk factors

  • High capital investment requirement: Continuous spending is needed for advanced diagnostic equipment, technology upgrades, and maintenance.
  • Regulatory and compliance dependence: Operations are subject to healthcare regulations, accreditations, and quality standards, which can increase operational complexity and costs.
  • Intense industry competition: Faces strong competition from large national diagnostic chains and local players, which may impact pricing power and profit margins.

Promoters

Mr. Devendra Singh Yadav

Mrs. Deepali Yadav

Mrs. Asha Yadav

Mr. Jitendra Singh

Registrar & documents

Lead manager

Beeline Capital Advisors Private Limited

Registered office

Plot No H-64,1st Floor BLK-H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West Delhi West Delhi, New Delhi, 110015

9999474297

[email protected]Company website ↗

Understanding MDRCL IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.